Biologics Safety Testing Market Driven by Monoclonal Antibody Expansion and Advanced Adventitious Agent Detection
The rapid expansion of complex biopharmaceutical drug pipelines—including monoclonal antibodies, recombinant proteins, and viral vectors—is driving demand for high-throughput safety testing assays. Detailed analysis within the Biologics Safety Testing Market report demonstrates that safety evaluation protocols are essential for detecting potential adventitious viral contamination,...
0 Commenti 0 condivisioni 643 Views 0 Anteprima